Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

Core Viewpoint - A securities fraud class action lawsuit has been filed against Soleno Therapeutics, Inc. for alleged misconduct related to the purchase of its common stock during a specified period [1] Group 1: Lawsuit Details - The lawsuit is filed on behalf of investors who purchased or acquired Soleno common stock between March 26, 2025, and November 4, 2025 [1] - The case is being heard in the United States District Court for the Northern District of California [1]